Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy

BJU International

Volumn 113, Issue 1, 2014, Pages 65-69

  Zehnder, Pascal ^a   Moltzahn, Felix ^c   Daneshmand, Siamak ^a   Leahy, Marya ^a   Cai, Jie ^a   Miranda, Gus ^a   Bartsch, Georg ^a   Mitra, Anirban P ^b   Skinner, Donald G ^a   Skinner, Eila C ^a   Gill, Inderbir S ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

bladder cancer; carcinoma in situ; carcinoma in situ (CIS); radical cystectomy; survival; urothelial cancer

Indexed keywords

BCG VACCINE; CISPLATIN; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; INTERFERON; MITOMYCIN; PACLITAXEL; THIOPENTAL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METACHRONOUS CANCER RECURRENCE; MULTIPLE CYCLE TREATMENT; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; URETHRA CARCINOMA; VAGINA CANCER; VERY ELDERLY;

BLADDER CANCER; CARCINOMA IN SITU; CARCINOMA IN SITU (CIS); RADICAL CYSTECTOMY; SURVIVAL; UROTHELIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CARCINOMA IN SITU; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84890569509     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12250     Document Type: Article

References (24)

1. Humphrey PA,. Urothelial carcinoma in situ of the bladder. J Urol 2012; 187: 1057-1058
2. Gudjõnsson S, Blackberg M, Chebil G, et al. The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS). BJU Int 2012; 110: E41-45
3. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011; 59: 997-1008
4. Stein JP,. Indications for early cystectomy. Urology 2003; 62: 591-595
5. Shariat SF, Palapattu GS, Amiel GE, et al. Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology 2006; 68: 538-542
6. Huang GJ, Kim PH, Skinner DG, Stein JP,. Outcomes of patients with clinical CIS-only disease treated with radical cystectomy. World J Urol 2009; 27: 21-25
7. Tilki D, Reich O, Svatek RS, et al. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol 2010; 183: 1757-1763
8. Hassan JM, Cookson MS, Smith JA Jr, Johnson DL, Chang SS,. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 2004; 172: 882-884
9. Williamson SR, Montironi R, Lopez-Beltran A, MacLennan GT, Davidson DD, Cheng L,. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art. Crit Rev Oncol Hematol 2010; 76: 112-126
10. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR,. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158: 62-67
11. Herr HW,. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105-108
12. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-2422
13. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675
14. Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I,. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol 2011; 60: 1266-1272
15. Palou J, Sylvester RJ, Faba OR, et al. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin. Eur Urol 2012; 62: 118-125
16. Cho KS, Seo JW, Park SJ, et al. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder. Urol Int 2009; 82: 306-311
17. Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C, Studer UE,. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 2010; 58: 486-494
18. Harris B, Mitra A, Skinner E, Miranda G, Daneshmand S,. Survival following urothelial recurrence in patients post-radical cystectomy for transitional cell carcinoma of the bladder. Western Section of the American urological Association Annual Meeting; 2011 August 21-25; Vancouver, BC. (abstract)
19. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
20. Takayanagi A, Masumori N, Takahashi A, Takagi Y, Tsukamoto T,. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors. Int J Urol 2012; 19: 229-233
21. Ploeg M, Kums AC, Aben KK, et al. Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent. Clin Genitourin Cancer 2011; 9: 14-21
22. Baumann BC, Guzzo TJ, He J, et al. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys 2013; 85: 81-88
23. Balbay MD, Cimentepe E, Unsal A, Bayrak O, Koc A, Akbulut Z,. The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 2005; 174: 2260-2263
24. El Hayek OR, Coelho RF, Dall'oglio MF, et al. Evaluation of the incidence of bladder perforation after transurethral bladder tumor resection in a residency setting. J Endourol 2009; 23: 1183-1186